Skip to main content
Premium Trial:

Request an Annual Quote

Harvard s George Grills Takes Post at Cornell Institute; Gene Express Names Vardzel CEO; David Haussler Awarded Dickson Prize; Sam Gambhir Joins Lumera Board; and Others

Genzyme announced today that Dick Syron has joined its board of directors.


Syron is CEO and chairman of Freddie Mac. Previously, he has served as CEO, president and chairman of the board at Thermo Electron. He was chairman of the American Stock Exchange from 1994 - 1999.

Gene Express named Gerald Vardzel CEO last week. He was also appointed assistant to chairman of the board.


Vardzel was previously vice president of business development at the company. Prior to Gene Express, he held several key management positions at Becton Dickinson. He has also been a consultant for small- to mid-size equity firms. He is a director for JKMP Group.

George Grills has taken the position of director of advanced technology assessment and director of operations of life sciences core facilities at the Cornell University Institute for Biotechnology and Life Science Technology.


Grills was formerly director of DNA sequencing at Harvard-PartnersGenomeCenter.

Carnegie Mellon announced yesterday that the Dickson Prize will be awarded to David Haussler.


Haussler is a professor of biomolecular engineering at UC Santa Cruz and an investigator at Howard Hughes Medical Institute. He is the scientific co-director of the California Institute for Quantitative Biomedical Research.


Haussler will receive $50,000 and deliver a public lecture at Carnegie Mellon on March 9.

Sam Gambhir has become a director at Lumera, the company said today.


Gambhir is a professor in the nuclear medicine division at Stanford University School of Medicine and as the director of the school's molecular imaging program.

Paul Bleicher has joined the board of directors of Teranode, the company said Monday.


Bleicher is the founder of Phase Forward, a clinical trial software provider. He has been medical director at Parexel International and vice president of clinical affairs at Alpha-Beta Technology.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.